Company Filing History:
Years Active: 2001-2010
Title: David J T Porter: Innovator in Cancer Treatment
Introduction
David J T Porter is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of cancer treatment through his innovative work. With a total of 7 patents to his name, Porter has focused on developing compounds that enhance the efficacy of existing cancer therapies.
Latest Patents
One of his latest patents involves uracil reductase inactivators, specifically a 5-substituted uracil or 5,6-dihydro-5-substituted uracil. These compounds are designed to potentiate 5-fluorouracil, a common chemotherapy drug, thereby improving its effectiveness in treating cancer. The 5-substituent in these compounds can be selected from various groups, including bromo, ido, cyano, halo-substituted alkyl, alkenyl, 1-halo-alkenyl, and halo-substituted alkynyl.
Career Highlights
Throughout his career, David J T Porter has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and SmithKline Beecham Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in cancer treatment.
Collaborations
Porter has collaborated with notable colleagues such as Thomas Spector and Saad George Rahim. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
David J T Porter is a distinguished inventor whose work in cancer treatment has the potential to make a significant impact on patient care. His innovative patents and collaborations highlight his commitment to advancing medical science.